# Coenzyme Q10 as Treatment for Long Term COVID-19

> **NCT04960215** · PHASE2 · COMPLETED · sponsor: **Aarhus University Hospital** · enrollment: 121 (actual)

## Conditions studied

- Covid19
- Long Term Covid19

## Interventions

- **DRUG:** Coenzyme Q10
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04960215
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-25
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2022-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04960215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04960215, "Coenzyme Q10 as Treatment for Long Term COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04960215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*